We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Allergy Therapeutics Plc | LSE:AGY | London | Ordinary Share | GB00B02LCQ05 | ORD 0.1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | |
---|---|---|---|---|---|
0.05 | 1.79% | 2.85 | 2.80 | 2.90 |
High Price | Low Price | Open Price | Shares Traded | Last Trade |
---|---|---|---|---|
2.875 | 2.80 | 2.80 | 919,062 | 09:00:28 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 59.59M | -43.07M | -0.0090 | -3.17 | 135.84M |
Date | Time | Source | Headline |
---|---|---|---|
03/4/2024 | 07:00 | UK RNS | Allergy Therapeutics PLC Director Resignation |
27/3/2024 | 16:13 | ALNC | EARNINGS AND TRADING: Solid State ups outlook; Quartix trading in line |
27/3/2024 | 07:00 | UK RNS | Allergy Therapeutics PLC Interim Results for six months ended 31 Dec 2023 |
27/3/2024 | 07:00 | UK RNS | Allergy Therapeutics PLC Update on funding |
12/3/2024 | 14:06 | ALNC | Allergy Therapeutics starts dosing patients in peanut allergy trial |
12/3/2024 | 08:59 | UK RNS | Allergy Therapeutics PLC VLP Peanut PROTECT Trial Update |
12/3/2024 | 07:00 | UK RNS | Allergy Therapeutics PLC VLP Peanut PROTECT Trial Update |
11/3/2024 | 07:00 | UK RNS | Allergy Therapeutics PLC Appointment of Shaun Furlong to Board of Directors |
08/3/2024 | 13:49 | UK RNS | Allergy Therapeutics PLC Result of AGM |
14/2/2024 | 10:22 | ALNC | Allergy Therapeutics forecasts revenue drop but trials going well |
1 Year Allergy Therapeutics Chart |
Intraday Allergy Therapeutics Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions